Patent intelligence · US
US 10940626
Manufacturing of small film strips
Manufacturing of small film strips
Patent details — US 10940626
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 9, 2021
- Expiration
- Mar 4, 2041
- Applicant
- Aquestive Therapeutics, Inc.
- Claims
- 20
- CPC classes
- A61K, A61K9/0014, A61K9/006, A61K9/7007
Quick answer
US 10940626 (Manufacturing of small film strips) is held by Aquestive Therapeutics, Inc.. Status: granted. Granted Mar 9, 2021. Expires Mar 4, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aquestive Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K9/0014, A61K9/006, A61K9/7007, A61K9/7084
More from Aquestive Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427121
Enhanced delivery epinephrine compositions
granted -
US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12290597
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12023309
Enhanced delivery epinephrine compositions
granted -
US 11541002
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 11273131
Pharmaceutical compositions with enhanced permeation
granted -
US 11191737
Enhanced delivery epinephrine compositions
granted -
US 11129799
Dual lane coating
granted
Related coverage
Frequently asked questions
What is US patent 10940626?
US 10940626 (Manufacturing of small film strips) is held by Aquestive Therapeutics, Inc.. Status: granted. Granted Mar 9, 2021. Expires Mar 4, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10940626?
Aquestive Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 17 pharmaceutical patents for this assignee.
When does US 10940626 expire?
Our index shows an expiration date of Mar 4, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.